Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis

医学 肝细胞癌 外科肿瘤学 内科学 单变量分析 外科 肝硬化 阶段(地层学) 肝癌 多元分析 生物 古生物学
作者
Lan‐Qing Yao,Zhengliang Chen,Zihan Feng,Yong‐Kang Diao,Chao Li,Haiying Sun,Jian‐Hong Zhong,Ting‐Hao Chen,Wei‐Min Gu,Ya-Hao Zhou,Wanguang Zhang,Hong Zhang,Yongyi Zeng,Han Wu,Ming-Da Wang,Xin‐Fei Xu,Timothy M. Pawlik,Wan Yee Lau,Feng Shen,Tian Yang
出处
期刊:Annals of Surgical Oncology [Springer Nature]
卷期号:29 (7): 4291-4303 被引量:84
标识
DOI:10.1245/s10434-022-11454-y
摘要

BackgroundA potentially curative hepatic resection is the optimal treatment for hepatocellular carcinoma (HCC), but most HCCs, even at an early stage, eventually recur after resection. This study investigates clinical features of initial recurrence and long-term prognosis of patients with recurrence after curative resection for early-stage HCC.Patients and MethodsFrom a multicenter database, patients who underwent curative hepatic resection for early-stage HCC [Barcelona Clinic Liver Cancer (BCLC) stage 0/A] were extracted. Time to initial recurrence, patterns of initial recurrence, and treatment modalities for recurrent tumors were investigated. Univariate and multivariate analysis were used to identify independent risks associated with postoperative recurrence, as well as post-recurrence survival (PRS) for patients with recurrence.ResultsAmong 1424 patients, 679 (47.7%) developed recurrence at a median follow-up of 54.8 months, including 408 (60.1%) early recurrence (≤ 2 years after surgery) and 271 (39.9%) late recurrence (> 2 years). Independent risks of postoperative recurrence included cirrhosis, preoperative alpha-fetoprotein level > 400 ug/L, tumor size > 5 cm, multiple tumors, satellites, microvascular invasion, and intraoperative blood transfusion. Multivariate analysis revealed that receiving irregular recurrence surveillance, initial tumor beyond Milan criteria, early recurrence, BCLC stage B/C of the recurrent tumor, and noncurative treatments were independently associated with poorer PRS.ConclusionsNearly half of patients with early-stage HCC experienced recurrence after resection. Understanding recurrence risks may help identify patients at high risk of recurrence who may benefit from future adjuvant therapies. Meaningful survival even after recurrence can still be achieved by postoperative regular surveillance and curative treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Lucas应助tianliyan采纳,获得10
刚刚
汉堡包应助花城采纳,获得10
刚刚
xy发布了新的文献求助10
刚刚
Ekko完成签到,获得积分10
刚刚
1秒前
万能图书馆应助HHZ采纳,获得10
1秒前
1秒前
夏日星辰完成签到 ,获得积分20
1秒前
1秒前
xiaoyi发布了新的文献求助10
1秒前
安详寒蕾完成签到,获得积分10
1秒前
bo发布了新的文献求助10
1秒前
1秒前
2秒前
英俊的铭应助哈哈哈哈采纳,获得10
2秒前
司马阁发布了新的文献求助10
2秒前
橙橙子发布了新的文献求助10
2秒前
王宇萱发布了新的文献求助10
2秒前
2秒前
2秒前
极少发生的重复性发作完成签到,获得积分10
3秒前
keyanbaicai发布了新的文献求助10
3秒前
yyds完成签到,获得积分10
3秒前
3秒前
3秒前
化学发布了新的文献求助10
4秒前
贝贝完成签到,获得积分10
4秒前
Jiang完成签到,获得积分10
4秒前
七星嘿咻发布了新的文献求助10
4秒前
5秒前
成就乐巧发布了新的文献求助10
5秒前
5秒前
研友_VZG7GZ应助十七采纳,获得10
5秒前
REBECCA发布了新的文献求助10
5秒前
清爽四娘发布了新的文献求助10
6秒前
6秒前
6秒前
张张发布了新的文献求助10
6秒前
7秒前
糊涂的康发布了新的文献求助10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Propeller Design 1000
Weaponeering, Fourth Edition – Two Volume SET 1000
First commercial application of ELCRES™ HTV150A film in Nichicon capacitors for AC-DC inverters: SABIC at PCIM Europe 1000
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 6000200
求助须知:如何正确求助?哪些是违规求助? 7498212
关于积分的说明 16096717
捐赠科研通 5145129
什么是DOI,文献DOI怎么找? 2757734
邀请新用户注册赠送积分活动 1733491
关于科研通互助平台的介绍 1630784